Primary Job Title CEO Primary Organization Dianosic
Location Paris, Ile-de-France, France Regions European Union (EU), Europe, Middle East, and Africa (EMEA) Gender Male
LinkedIn View on LinkedIn
Philippe has more than 20 years of experience in the pharmaceutical and MedTech industries. He began his career at Pfizer, where he developed strong expertise in market research, market access, and pricing, with a particular focus on central nervous system (CNS) disorders.
He then joined Johnson & Johnson, where he was responsible for Market
Access for Ethicon Biosurgery across the EMEA region (Europe, Middle East, and Africa).
Within J&J, Philippe continued his career at Acclarent, where he led the establishment and development of the company’s operations in France and the Benelux. In this role, he actively contributed to the launch and commercial development of new therapies, with responsibilities extending to pre-commercial markets across EMEA as well as to Professional Education programs.
He subsequently joined LivaNova’s New Ventures division, where he worked in Global Market Access, supporting internal innovation projects and partner startups, from strategic structuring through to operational development.
More recently, Philippe co-founded Dianosic, a deeptech startup developing long-acting intranasal drug-delivery platforms aimed at transforming the management of chronic respiratory diseases and opening new therapeutic pathways in central nervous system disorders. By leveraging long-acting resorbable solid formulations, Dianosic aims to improve treatment efficacy, patient adherence, and overcome key drug-delivery limitations, particularly in accessing the brain via the nasal route.
